Last Commented Health Blogs (952)

As reported in the New York Times yesterday, the results are in from the first carefully controlled trial
which exposed 821 people to others with Covid-19. No difference from the control group.
"What have you got to lose ?" Time, money, hope, and side effects, including heart problems.
Plus, it may prevent you from taking something that does work.



Please stick to doing your actual job Mr. "so-called" president and stop pretending you know it all.
The truth is, that you are a dope !

The government employee quality epidemiologists at the WHO, (is my fat pension ready yet?), stopped their study of this issue early, raising ethical grounds.They claimed a slight increase of mortality in the non placebo arm of their analyses. Notably, the method of sequential trials doesn't seem to have been employed. And the specific causes of death could have been better characterized. The many biostatisticians at the New York Times might consider ongoing edumacation.
We now see growing new, more valid, evidence, beginning with the results of the largest study to date, that such differences may not exist. And even if these were there in the data, and true, if small, allow the use of a medicine, using prudent clinical judgment. As with nearly all agents to date. Even aspirin and acupuncture. I've blogged on the details of such, especially with the connections between heart and lung and inflammatory illnesses.
Trump Derangement-Hilary Deficit Syndrome may be progressive. Back to the drawing boards.
I again thank some here for both content of ideas, and ad hominem comments on physiognomy. Both entertain, have validity and are a clue to character.

HUGE DEVELOPMENT! … Now 3 International Studies Find Chloroquine with Azithromycin Shows 100% Success Rate in Treating Coronavirus in 6 Days!

There are now THREE international studies — China, Australia and France — that found that Chloroquine with Azithromycin Shows 100% Success Rate in Treating Coronavirus in 6 Days!

We have reported on the success of Chloroquine earlier today and this week.

President Trump announced on Thursday morning that the CDC had approved use of the drug in treating coronavirus patients.

But tonight we heard more from Rep. Mark Green, a former Army Flight Surgeon, that the combination of Chloroquine with Azithromycin cleared the virus in 3 days in 100% of the patients in the study.

That is THREE international studies now that show the success of the Chloroquine treatment.

Read more and watch:

Sure, the wonders of spring cheer many of us up. I have been experiencing my first real serious (not yet delirious) existential variety of clinical depression. No Azores this year, so far. Lock down and the excuse of sloth, put on a few Kg's. Too much choice in life. The vagaries of my kids' lives. And so on. Then C-19, to really put a little frosting on it all.
I used to wonder what such blues really were, and even doubted the validity of such, as I sent my charges on to electro convulsive treatments, after many things were tried, and failed. Including when, even drug combinations, weren't nearly enough. The sort of folks who can't be left out of sight for even a day or two, noose and pistols ever at the ready. This is the land of the free and brave, after all.
But it's a gift to really know in the flesh, that treetop depression exists, and more importantly, how it suits one. And my hottie doctor psychologist, of nearly two decades, now wants to use Zoom. I hate Zoom. So it's of to the apothecary. When things work, they usually continue to do so.
But my ex next door called excitedly to say she saw the first pair of these incredible penny weight critters. Off to the store to buy a colorful feeder, self mixing of "nectar", cheap gnome that I am, and it's now up among the other feeders, visible through the bay window, fascinating both Bravo and meself.
Instant lifting of mood. Even the fruit and berry blossoms, planting the garden, watching Bravo fearlessly chase the chimp monks, and fast paced walking weren't enough. But those little birds, arriving on the wing from some 7,000 KM away, to the same spot, easily fending of birds many times their size, in full helo form---now THAT is the rub.

I haven't experienced COVID-19 testing first hand. Should I need to, there are few centers near me, one being about a mile away. I see in local news, Home Depot has setup testing centers in their parking lots. I'll have to pass by one this weekend and see how many are in line.
Some people report there are no lines... does that mean less people with symptoms? That's a good thing in my book. If it's because people are apathetic, that could be a bad thing as asymptomatic carriers could unknowingly infect others.

A friend of mine works in a busy office and required to wear a mask when outside of his cubicle.

I heard one of the local manufacturing companies had a worker test positive. They shut down for 2 days and had a crew come in to sanitize the place. Routine testing is now required for the workers.

Testing, testing, testing... That's the only way to stay ahead of the trouble.

Trump announces he's taking hydroxychloroquine and days later people are trying to home brew their anti-covid-19 remedies.
Here we go again with folks. News yesterday said Schweppes tonic water with quinine has disappeared off the grocers shelves and they are predicting a rise in poisonings with 'monkey see monkey do' folks trying any similar defense to the COVID-19 pandemic.

...and you though no one would be so gullible to try bleach injections, this one could be exponential!

Seeking to secure the nation's supply of critical medications, the Trump administration has signed a $354 million contract that would create the nation's first strategic stockpile of key ingredients needed to make medicines.

The agreement was signed Monday with Phlow Corp., a generic drug maker based in Virginia. According to a news release to be made public Tuesday, the project will use federal funds from the Biomedical Advanced Research and Development Authority under the Department of Health and Human Services.

The goal is twofold: to enable the U.S. to manufacture essential drugs at risk of shortage and to create a reserve of active pharmaceutical ingredients to reduce the dependence on foreign suppliers.

Phlow's CEO, Dr. Eric Edwards, told NBC News that the company had been in discussions with the administration back in November but that the project was fast-tracked once COVID-19 hit.

"We said: 'We have a short-term and long-term solution. We know that there are certain key essential generic medicines that are going to go into shortage if this thing starts spreading,'" Edwards said. "There were drugs that were already on the FDA drug shortage list long before COVID-19 and we already saw what was happening with PPE, and we knew this was going to be as bad or even worse."

"PPE" is short for personal protective equipment used by medical personnel.

Edwards said the company is set to provide more than a dozen medications and ingredients used for sedation, pain management, blood pressure control and antibiotics. It has already produced over 1.6 million doses of five essential generic drugs used to treat COVID-19 that were added to the U.S. Strategic National Stockpile in March.

Phlow will be manufacturing the drugs in partnership with the nonprofit pharmaceutical company Civica Rx, Virginia Commonwealth University and AMPAC Fine Chemicals, a manufacturer of active pharmaceutical ingredients. The total value of the Phlow contract is up to $812 million, which includes the possibility of an additional $458 million to keep the project going long term. It was first reported by The New York Times.

"This is an historic turning point in the battle of President Trump to bring our pharmaceutical manufacturing and supply chain home to American soil," White House trade adviser Peter Navarro told NBC News.

The move would help address a longstanding concern in the health care sector, experts said, as the vast majority of raw drug ingredients are produced overseas, mainly in India and China because of cheap manufacturing costs and less stringent regulations. Experts have long feared a significant supply disruption caused by the country's dependence on foreign manufacturing.

The coronavirus pandemic has forced hospitals to scramble to source critical medications for COVID-19 patients. In some cases, fear of shortages has created a competitive landscape among health care providers seeking the same medications.

Arash Dabestani, senior director of pharmacy at NYU Langone Health in New York, said getting the necessary drugs often involves a team of six people making calls to wholesalers, distributors and direct manufacturers as early as 9 a.m. And even then, they may get only half the supply they really need.

"It's like an auction," Dabestani said. "Whoever screams the loudest gets it."

Read more:

Why would Congress name a bill that in the first place? Why not HR 5555?

Anyway, I just recently heard about this and very briefly read about it and don't know much about the specfics the bill talks about. I am just interested in knowing why they would name it that? A bill....that makes it, from my understanding, mandatory for us to receive a vaccine.


anyway....

This SHOULD go without saying, BUT.....
Lets just say, that in no large group is everyone going to be
of the same intelligence. That will not happen.
We are unique individuals.
Having read some of the things I see on here,
believe it or not, I truly worry about some of you especially after witnessing
how some of you are easily mislead.

Thus, just in case the hydroxychloroquin mishaps were not enough,
please do not inject disinfectant, no matter what the idiot-in-chief says.
And in case there are any doubts, here is the words of the FDA commissioner on this topic;

From CNN;